releases: https://susanwbrooks.house.gov/media-center/press-releases/brooks-votes-against-jeopardizing-biomedical-american-innovation
Data license: MIT · Data source: dwillis/congress-press
This data as json
| url | title | date | year | month | party | chamber | state | member_name | bioguide_id | domain | scraper | source | date_source | text | has_text | collected_at | updated_at |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| https://susanwbrooks.house.gov/media-center/press-releases/brooks-votes-against-jeopardizing-biomedical-american-innovation | Brooks Votes Against Jeopardizing Biomedical American Innovation | 2019-12-12 | 2019 | 2019-12 | Republican | House | IN | Susan Brooks | B001284 | susanwbrooks.house.gov | legacy | WASHINGTON, DC Today Congresswoman Susan W. Brooks (R-IN05) provided the following statement after voting against H.R.3: Every cure we do not discover isalife wewillnot save. Congress has found a bipartisan solution to lower drug costs while ensuring the United States will continue to be on the cutting edge of biomedical research, innovation and breakthrough medicines to develop cures,said Rep Brooks.I am disappointed the majority did not advance this bipartisan legislation that has a real chance of being signed into law today to provide real relief for Americans. Instead Democrats moved H.R. 3, which, according to the Congressional Budget Office would result in 15 fewer cures being developed. The Council of Economic Advisers says that number is likely closer to 100 fewer cures. H.R. 19,The Lower Costs, More Cures Actis the solution to lower drugs costs and protects our seniors by capping out of pocket costs. We know this bipartisan language would have workedthrough the Senate andbeensigned into law by the president. To watch Brooks' remarks on the House Floor, clickhere. ### | 1 | 2026-03-30T12:14:52Z | 2026-03-30T12:14:52Z |